Literature DB >> 8855267

Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP alpha, -beta, and -delta during granulocyte-lineage specification.

A M Ford1, C A Bennett, L E Healy, M Towatari, M F Greaves, T Enver.   

Abstract

We have compared the molecular architecture and function of the myeloperoxidase upstream enhancer in multipotential versus granulocyte-committed hematopoietic progenitor cells. We show that the enhancer is accessible in multipotential cell chromatin but functionally incompetent before granulocyte commitment. Multipotential cells contain both Pu1 and C-EBP alpha as enhancer-binding activities. Pu1 is unphosphorylated in both multipotential and granulocyte-committed cells but is phosphorylated in B lymphocytes, raising the possibility that differential phosphorylation may play a role in specifying its lymphoid versus myeloid functions. C-EBP alpha exists as multiple phosphorylated forms in the nucleus of both multipotential and granulocyte-committed cells. C-EBP beta is unphosphorylated and cytoplasmically localized in multipotential cells but exists as a phosphorylated nuclear enhancer-binding activity in granulocyte-committed cells. Granulocyte colony-stimulating factor-induced granulocytic differentiation of multipotential progenitor cells results in activation of C-EBP delta expression and functional recruitment of C-EBP delta and C-EBP beta to the nucleus. Our results implicate Pu1 and the C-EBP family as critical regulators of myeloperoxidase gene expression and are consistent with a model in which a temporal exchange of C-EBP isoforms at the myeloperoxidase enhancer mediates the transition from a primed state in multipotential cells to a transcriptionally active configuration in promyelocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855267      PMCID: PMC38242          DOI: 10.1073/pnas.93.20.10838

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Immunoglobulin heavy-chain and CD3 delta-chain gene enhancers are DNase I-hypersensitive in hemopoietic progenitor cells.

Authors:  A M Ford; C A Bennett; L E Healy; E Navarro; E Spooncer; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 2.  GATA-binding transcription factors in hematopoietic cells.

Authors:  S H Orkin
Journal:  Blood       Date:  1992-08-01       Impact factor: 22.113

3.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Authors:  J M Pongubala; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

Review 4.  Chromatin as an essential part of the transcriptional mechanism.

Authors:  G Felsenfeld
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

5.  Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.

Authors:  Z Cao; R M Umek; S L McKnight
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

6.  Phosphorylation of CCAAT-enhancer binding protein by protein kinase C attenuates site-selective DNA binding.

Authors:  C W Mahoney; J Shuman; S L McKnight; H C Chen; K P Huang
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

7.  cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription.

Authors:  R Metz; E Ziff
Journal:  Genes Dev       Date:  1991-10       Impact factor: 11.361

8.  Multilineage phenotypes of interleukin-3-dependent progenitor cells.

Authors:  A M Ford; L E Healy; C A Bennett; E Navarro; E Spooncer; M F Greaves
Journal:  Blood       Date:  1992-04-15       Impact factor: 22.113

9.  A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells.

Authors:  L M Scott; C I Civin; P Rorth; A D Friedman
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

10.  Activation of the beta-globin locus control region precedes commitment to the erythroid lineage.

Authors:  G Jiménez; S D Griffiths; A M Ford; M F Greaves; T Enver
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more
  26 in total

1.  Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb.

Authors:  M Britos-Bray; A D Friedman
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis.

Authors:  Li Chai
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

3.  Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.

Authors:  Barry Heavey; Christoforos Charalambous; Cesar Cobaleda; Meinrad Busslinger
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

4.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.

Authors:  D E Zhang; P Zhang; N D Wang; C J Hetherington; G J Darlington; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 5.  The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis.

Authors:  Shelley M Lawrence; Ross Corriden; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2018-02-07       Impact factor: 11.056

6.  CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing.

Authors:  R Yamanaka; G D Kim; H S Radomska; J Lekstrom-Himes; L T Smith; P Antonson; D G Tenen; K G Xanthopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 7.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

Review 8.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

9.  High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.

Authors:  Ji Suk Chang; Ramasamy Santhanam; Rossana Trotta; Paolo Neviani; Anna M Eiring; Edward Briercheck; Mattia Ronchetti; Denis C Roy; Bruno Calabretta; Michael A Caligiuri; Danilo Perrotti
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

10.  ZNF143 protein is an important regulator of the myeloid transcription factor C/EBPα.

Authors:  David Gonzalez; Annouck Luyten; Boris Bartholdy; Qiling Zhou; Miroslava Kardosova; Alex Ebralidze; Kenneth D Swanson; Hanna S Radomska; Pu Zhang; Susumu S Kobayashi; Robert S Welner; Elena Levantini; Ulrich Steidl; Gilbert Chong; Samuel Collombet; Min Hee Choi; Alan D Friedman; Linda M Scott; Meritxell Alberich-Jorda; Daniel G Tenen
Journal:  J Biol Chem       Date:  2017-09-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.